WebDec 20, 2024 · Our investigational T-cell therapies target difficult-to-treat Epstein-Barr virus (EBV)-driven conditions, including certain cancers and multiple sclerosis, as well as a … The Atara Biotherapeutics Management Team. Dan Maziasz Head of Corporate … View All Presentations. Email Alerts. Sign up for email alerts for Press Releases & … Atara Biotherapeutics Environmental, Social, and Governance. With a Board … Atara Biotherapeutics 12635 East Montview Blvd, Suite 312 Aurora, CO 80045 (650) … Find more than a career, Help find solutions. Fill out general application, … Atara Biotherapeutics is followed by the analysts listed above. Please note that … Our clinical studies evaluate the potential of our investigational treatments in a well … http://www.functionalnet.org/aranet/

Management Team - Atara Biotherapeutics

WebOct 26, 2024 · For additional information about the company, please visit atarabio.com and follow us on Twitter and LinkedIn. Forward-Looking Statements. This press release contains or may imply “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For … WebApr 4, 2024 · Atara Biotherapeutics, Inc. (@Atarabio) is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies … gps village of valley stream

Aranet - Probabilistic Functional Gene Network of A. thaliana

WebJan 26, 2024 · Atara Biotherapeutics, Inc. (@Atarabio) is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. With our lead program in Phase 3 clinical development and currently under ... Web205 Study. A study to evaluate tabelecleucel in participants with Epstein-Barr virus-associated diseases*. REQUEST INFO clinicaltrials.gov. *EBV-associated diseases being studied include: EBV + lymphoproliferative disease (LPD) in the setting of primary immunodeficiency (PID) (PID LPD); EBV + LPD in the setting of acquired (non-congenital ... WebMar 11, 2024 · View Bryan Kadotani's verified business profile as Associate Director, Clinical Program Management at Atara Bio. Find contact's direct phone number, email address, work history, and more. gps visualiser draw on map